Dennis T. Mangano

TL;DR: In patients who have or are at risk for coronary artery disease who must undergo noncardiac surgery, treatment with atenolol during hospitalization can reduce mortality and the incidence of cardiovascular complications for as long as two years after surgery.

TL;DR: The association between aprotinin and serious end-organ damage indicates that continued use is not prudent, and the less expensive generic medications aminocaproic acid and tranexamic acid are safe alternatives.

TL;DR: The Multicenter Study for Perioperative Ischemia (McSPI) Research Group studied 2400 patients who underwent myocardial revascularization with cardiopulmonary bypass to determine the incidence and characteristics of postoperative renal dysfunction and failure, the predictors of renal dysfunction [determined by the use of multivariate modeling techniques], and the effect of kidney dysfunction on in-hospital resource utilization and patient disposition after discharge.

TL;DR: What specific tests are available for assessment of patients with IHD and what information can be obtained from these tests to determine perioperative risk, preoperative therapeutics, intraoperative monitoring, choice of anesthetic, and postoperative care is needed.

TL;DR: The findings suggest that treatment with β-blockers, ACE inhibitors, and/or nonsteroidal anti-inflammatory drugs may offer protection in patients at risk for atrial fibrillation after CABG surgery.